DURECT Corp (NASDAQ:DRRX)
| 5.74 Delayed Data As of Jun 02 |  -0.43 / -6.97%Today’s Change | 3.17 Today|||52-Week Range 9.70 | +65.90% Year-to-Date |
Latest DRRX News | Press Releases
No recent news for DURECT Corp.
Today’s Trading
| Previous close | 6.17 |
| Today’s open | 6.21 |
| Day’s range | 5.56 - 6.21 |
| Volume | 5,701 |
| Average volume (3 months) | 106,709 |
| Market cap | $140.9M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +3.73% |
| Earnings growth (this year) | -15.81% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +37.96% |
| P/E ratio | NM |
| Price/Sales | 4.09 |
| Price/Book | 5.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACHVAchieve Life Science... | +0.27 | +4.18% |
| --Immunovia AB (publ) | 0.00 | 0.00% |
| ---- | ||
| GTHXG1 Therapeutics Inc | +0.08 | +3.16% |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $19.3M |
| Annual profit (last year) | -$35.3M |
| Net profit margin | -183.23% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cupertino, California |
Forecasts
